4DMedical Ltd
ASX:4DX

Watchlist Manager
4DMedical Ltd Logo
4DMedical Ltd
ASX:4DX
Watchlist
Price: 6.1 AUD -4.69% Market Closed
Market Cap: AU$3.5B

4DMedical Ltd
Total Current Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

4DMedical Ltd
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
4DMedical Ltd
ASX:4DX
Total Current Liabilities
AU$9.7m
CAGR 3-Years
-18%
CAGR 5-Years
25%
CAGR 10-Years
N/A
CogState Ltd
ASX:CGS
Total Current Liabilities
$12.9m
CAGR 3-Years
-6%
CAGR 5-Years
-7%
CAGR 10-Years
13%
Pro Medicus Ltd
ASX:PME
Total Current Liabilities
AU$49.2m
CAGR 3-Years
26%
CAGR 5-Years
30%
CAGR 10-Years
22%
Alcidion Group Ltd
ASX:ALC
Total Current Liabilities
AU$22.3m
CAGR 3-Years
5%
CAGR 5-Years
18%
CAGR 10-Years
57%
A
Artrya Ltd
ASX:AYA
Total Current Liabilities
AU$2.1m
CAGR 3-Years
0%
CAGR 5-Years
67%
CAGR 10-Years
N/A
B
BlinkLab Ltd
ASX:BB1
Total Current Liabilities
AU$642.8k
CAGR 3-Years
53%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

4DMedical Ltd
Glance View

4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-08-07. The firm is focused on development of a non-invasive respiratory imaging solution using four-dimensional imaging. The firm's XV Technology is a four-dimensional lung imaging technology that utilizes mathematical models and algorithms to convert X-ray scans into quantitative data for physicians to manage patients with respiratory diseases and diseases of the lung. The XV Technology is accessible through a cloud-based software as a service (SaaS) platform that integrates with existing hospital equipment. The XV Technology Lung Ventilation Analysis Software (XV LVAS Ventilation) provides a non-invasive way of understanding regional lung motion and airflow. The company enables physicians to detect areas of high and low ventilation from all parts of the lung, in all phases of the breath.

4DX Intrinsic Value
0.1 AUD
Overvaluation 98%
Intrinsic Value
Price AU$6.1

See Also

What is 4DMedical Ltd's Total Current Liabilities?
Total Current Liabilities
9.7m AUD

Based on the financial report for Dec 31, 2025, 4DMedical Ltd's Total Current Liabilities amounts to 9.7m AUD.

What is 4DMedical Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
25%

Over the last year, the Total Current Liabilities growth was -56%. The average annual Total Current Liabilities growth rates for 4DMedical Ltd have been -18% over the past three years , 25% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett